I understand completely the difficulties that you are having with Busch and only hope, for your sake and for the sake of the
other investigators working on yeast, that you may eventually be able to clear up the difficulties that now confront you in
sending out cultures. We, of course, are in nothing like the same circumstances as the others who want your cultures, since
we wanted them for classroom use only. Thanks for your kind offer to send the diploid adaptable strains, but I think we must
pass up your offer because our primary purpose would be to demonstrate some of the genetic phenomena rather than adaptation.
You have probably already seen the answer to your question about Preer's work for it has appeared in the current issue
of the Proceedings of the National Academy.
I was particularly happy to hear that Lindegren is revising his C.S.H. manuscript so that much of the discussion will become
unnecessary. That would seem to me a much better way of doing things and I hope that it might be arranged that the discussors
of his paper can see his revision so as to make corresponding changes in the discussion. I heard some comments about the
St. Louis Missouri Botanical Garden Symposium which I hope will not be repeated about the C.S.H. Symposium. Apparently, there
were some revisions in the manuscripts that made much of the discussion pointless, yet the discussers were not informed of
the manuscript changes, and the consequence was that part of the discussion seemed quite pointless in print. I think you
would do a good deed all around if you could use your influence to see that such blunders do not happen with respect to the
C.S.H. papers. I should be glad, for example, if you would suggest to Lindegren that he and I exchange manuscripts in order
to adjust our discussions correspondingly. I would be glad to make this suggestion myself, but I think that taking everything
into consideration it might be more effective if it were initiated by a third person.
Our work on the killer substance has progressed with very gratifying rapidity within the last few months, and I hope to have
an opportunity to discuss the matter with you at some length, perhaps in Boston if not sooner. As soon as I found out that
we were to have a Biochemist, I made up my mind that the most practicable approach would be to concentrate first on the killer
stuff itself, not kappa. I concentrated our efforts on pushing as far as possible our knowledge of this substance (which
we now call paramecin) so as to get the Biochemist off to as good a start as possible. I think the decision was a wise one
because our efforts have paid off to an unexpected degree.
You have certainly put your finger on the critical problems in your own work, and, though they are tough as you well know,
I think it will turn out in the end that your plan of attack is a wise one.